ABCB1 and COVID-19: In addition, care should be taken in prescribing P-glycoprotein (P-gp) inhibitors for COVID-19 patients having acute hepatotoxicity after receiving remdesivir treatment as remdesivir probably interacts with P-glycoprotein (P-gp) inhibitors (86).